Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development
If a genetic cause is suspected, specialized testing may be recommended
Short chain fatty acids and gut microbiota differ between patients with Parkinsons disease and age-matched controls
What the clinical trials reveal about BMI and weight loss outcomes The clinical trial data offers the most rigorous evidence we have about how GLP-1 medications perform across different BMI categories
There is a large potential for variation in results according to the assay used, and support for the authenticity of a given assay is best generated by showing a correlation with an in vivo outcome
Resources like our guide on semaglutide and energy levels provide additional strategies for managing side effects that affect daily functioning